Opsona Therapeutics - validates and develops new drug candidates and strategies which modulate innate immune systems. Founders include Luke O'Neill and Kingston Mills
http://www.opsona.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.8 seconds
16x16
Opsona Therapeutics
Mary Reilly
Second Floor ●●●●●●●●●●●●● Tara Street
Dub●●●n 2 , Co. Dublin, D2
IE
View this contact
Strata3
Shona Healy
10 Wes●●●●●●Square
Dub●●●n 2 , Dublin, D2
IE
View this contact
Techsure Ltd
Peter Doherty
Lincoln House●●●●●●●●●●●●●ne,Smithfield
Dub●●●n 7 , Co. Dublin, n/a
IE
View this contact
BUY YOUR DOMAIN
20
YEARS
2
MONTHS
9
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
6
SITE IP
46.245.209.22
LOAD TIME
0.813 sec
SCORE
6.2
Opsona Therapeutics - leader in drug development in immunology research - Ireland | opsona.com Reviews
https://opsona.com
Opsona Therapeutics - validates and develops new drug candidates and strategies which modulate innate immune systems. Founders include Luke O'Neill and Kingston Mills
opsona.com
About Opsona Therapeutics - Opsona Therapeutics - Ireland
http://www.opsona.com/about
About Opsona - leaders in innate immune drug development. Opsona Therapeutics is one of Europe's most innovative and dynamic drug development companies. We are at the forefront of drug development in immunology research, with particular focus on the innate immunity pathways. Since its founding in 2004, Opsona has validated and developed a series of exciting new drug candidates and strategies which modulate the human innate immune system. We are located in Dublin, Ireland.
Partnerships - Wyeth, Phylogica, Shering-Plough - Opsona Therapeutics - Ireland
http://www.opsona.com/partners
Opsona Therapeutics works with leading partners. Developing and maintaining partnerships is a top priority at Opsona, and we have a strong track record of collaboration with academic and pharmaceutical partners. With leading international biopharmaceutical companies such as CSL, MSD and Pfizer reflect our ability to deliver and the significant interest in our unique approach. For new opportunities and further information. Read our latest Press Releases. Opsona Therapeutics 2013 website by Strata3.
Disclaimer - Opsona Therapeutics - Ireland
http://www.opsona.com/disclaimer
This website http:/ www.opsona.com/. IF YOU DO NOT ACCEPT THESE TERMS PLEASE LEAVE THIS SITE NOW. All references to “our”, “us”, “we”, “Company” or “Opsona” within these Terms are deemed to refer to Opsona Therapeutics Limited. You should always verify the information set out in this Site with independent authorities before acting or relying on it. LINKS FROM AND TO THE SITE. Opsona respects and protects the privacy of the individuals who access the Site. For full details of the manner in which Opson...
Meet the Opsona team
http://www.opsona.com/events
Conferences and Events 2016. 8th Annual Biotech showcase 2016. URL: http:/ www.ebdgroup.com/bts/index.php. The 18th Annual BIO CEO and Investor Conference. URL: https:/ www.bio.org/events/conferences/bio-ceo-investor-conference. American Society of Transplant. URL: https:/ www.myast.org/meetings/ceot-2016-resolving-organ-shortage. Future Leaders in the Biotech Industry. URL: http:/ www.biocentury.com/conferences/futureleaders/dates. 13th Annual BIO Asia International Conference 2016.
Opsona Therapeutics - leader in drug development in immunology research - Ireland
http://www.opsona.com/index.jsp?p=95&n=117
OPN-305, our antibody to reduce pro-inflammatory cytokine production, is now in clinical testing. Our goal is to improve the quality of life for patients with immune related diseases. Our research helps prevent and treat a range autoimmune diseases and cancers. Our innovations modulate the immune system and target autoimmune diseases. Opsona Therapeutics is a leading clinical stage biopharmaceutical company focused on the treatment of autoimmune/inflammatory diseases and cancers. Sign up for email alerts.
TOTAL PAGES IN THIS WEBSITE
11
DRIMARCH friends
http://www.drimarch.com/friends.php
Healthy Milk for Mali. Excellence in grain, seed and bean sorting. Accurate treatment for autoimmune diseases. Universität St. Gallen. Freedom to mime anatomy.
Euromedica | Thriving Communities
http://www.euromedica.com/papers-articles/thriving-communities
News & Opinions. Papers & Articles. 28 June 2016, ON Helix 2016. 7th July 2016, IET London,. News & Opinions. Papers & Articles. Single,single-post,postid-21875,single-format-standard,ajax fade,page not loaded, select-theme-ver-1.7.1,vertical menu enabled,wpb-js-composer js-comp-ver-4.3.5,vc responsive. June 18, 2015. The German-born CEO of drug developer Opsona. Head of Kits and Assays at Cambridge-based Abcam. Were also a draw. Getting to meet such talented people, including key opinion leaders at some...
Active Invests - EMBL Ventures
http://www.embl-ventures.com/index.php/portfolio/active-invests
Contact: www.allecra.com. Contact: www.arsanis.com. Status: Platform established, drug development in preclinic. Activity: human VH platform; in-house drug development in Psoriasis and Oncology. Contact: www.crescendobiologics.com. Activity: Therapeutic anti-infectives vaccines. Contact: www.imevax.com. Status: Clinical phase II / III. Activity: Drug Development, Cancer Vaccines. Contact: www.immatics.com. Status: Partnered - Clinical phase III. Activity: Drug Development , Colitis Ulcerosa.
Biotech Outsourcing Strategies cmc 2015
http://www.bio2bevents.com/forthcoming-events/bos-cmc-2015
Accesskey="1" p Biotech Outsourcing Strategies em cmc /em 2015 /p. Attending Biotech and Pharma. Attending Biotech and Pharma logo and links. Welcome to Biotech Outsourcing Strategies. 2015, the partnering event for CMC outsourcing. With a new location and a new two-day format the 8. Event is evolving to deliver more partnering, increased networking and greater opportunities to develop skills and knowledge in pharmaceutical CMC outsourcing. Dr Signe Maria Christensen. Head of Biotech Projects.
Links We Like
http://www.silverbark.ie/links-page.php
Acquired Brain Injury Ireland. South Dublin County Council. Post Primary Education Forum. Ballycannon, Kilcock,. T: 353 1 610 3183. M: 353 86 125 2570. Directors: Noel Smyth, Lisa Gilton SilverBark Creative Limited Reg No. 478656. Acquired Brain Injury Ireland. South Dublin County Council. Post Primary Education Forum.
Attendees | Sofinnova Biopharma Partnering Conference 2016
http://www.sofinnovajapanpartnering.com/attendees.php
October 25, 2016. In previous years, the conference has attracted over 150 licensing and business development executives from Japan, and more than 40 European and North American biotechnology companies. Below we have listed our stellar list of presenting companies, and a sample of the companies that attended in the past. Please refer back to this page for updated information. 2016 Attending Companies to Date. DS Pharma Animal Health. DS Pharma Animal Health. 2016 Sofinnova Ventures, Inc.
TOTAL LINKS TO THIS WEBSITE
6
Search Engine Marketing and Social Media Management | Opson, Inc.
Leverage the reach of Social recruiting and referral marketing to hire a talent at fraction of the cost. Opson helps online retailers increase qualified traffic to their online storefronts and convert visitors into buyers. Opson generates thousands of qualified leads daily for its clients through online and offline mediums. Harnessing the power of Social Media, Opson helps its clients build brands, strengthen customer relationships and develop new products by engaging in meaningful conversations. Our cli...
Opson.net
This domain may be for sale. Backorder this Domain. This Domain Name Has Expired - Renewal Instructions.
Opson.org
This domain may be for sale. Backorder this Domain. This Domain Name Has Expired - Renewal Instructions.
Opson.pl – miejsce luźnej i swobodnej analizy nowych technologii
Pre-view platformy LGA1150 – na przykładzie płyty ASRock Z87 Extreme4. Już niebawem na łamach opson.pl będę prezentował pojedyncze testy płyt głównych opartych o nowy chipset Intela Z87. Na początek jednak krótki pre-view który przygotowałem na blogu pclaba. Ponieważ miałem okazję przyjrzeć się z bliska płycie głównej AsRock Z87 Extreme4. Postanowiłem. Historia pewnego malucha z Allegro – czyli do czego prowadzi nieodpowiedzialne korzystanie z internetu. Carmageddon to niewątpliwie jedna z najbardziej ko...
Blog de opson - opson-team - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Enu 199 : Theo-doruse. Cra 195 : Krac-ramer. Eni 187 : Emergency-soigner. Sacri 195 : Sumardatson. Panda 175 : Adnap-vulnerability. Xelor 174 : Tessier. Feca 184 : Sergent-weed. Osa 160 : Theo-spando. Mise à jour :. Abonne-toi à mon blog! Retour du blog premier article! Ensuite j'ai arrêté mon iop 184, sa m'a bien aidé avec la revente des stuffs, j'en reparlerais plus tard! Je l'ai restats agilité plutôt que eau c'est beaucoup mieux! Je vais bientôt commencer...
Opsona Therapeutics - leader in drug development in immunology research - Ireland
OPN-305, our antibody to inhibit TLR2-mediated inflammation, is now in clinical testing. Our goal is to improve the quality of life for patients with immune related diseases. Our research helps prevent and treat a range autoimmune diseases and cancers. Our innovations modulate the immune system and target autoimmune and cancer diseases. Opsona Therapeutics is a leading clinical stage biopharmaceutical company focused on the treatment of autoimmune/inflammatory diseases and cancers. Through innovation and...
Ops! Ona...
He acabat els exàmens. Cal que expliqui les notes? Bé, no deu interessar a gaire ningú, això. Tot aprovat, excepte una, que no m'hi vaig presentar. Em vaig acollonir, sí. Ara deu tocar repòs, reflexió i agafar una mica de forces per al nou quatrimestre. Passarà ràpid. Disculpes per la pausa. Ara torno. Posted by Marduix Gebrat at 19:51. Hauré deixat d'escriure per només mecanografiar? No vull seguir un ritme així, he de descansar i deixar de banalitzar la resta del món. Redéu, que diria el meu avi, f...
We harness the cloud for you
Click to request a quote. How may we help you? How may we help you? How may we help you? How may we help you? How may we help you? How may we help you? How may we help you? How may we help you? Or Call 1 (415) 531 9848. Cloud Solutions for Small and Medium-Sized Enterprises. Hybrid Cloud and Private Cloud Infrastructure. Use our dedicated team to migrate your enterprise to the cloud. We harness the power of cloud infrastructure for you. We provide Hybrid and Private Cloud Infrastructure. Full Service Lev...
OPSONE
Opsone
Opsone est fière de lancer la 3ème version de son site! Une présentation plus claire de nos projets ainsi que de notre expertise métier. Opsone est agréée Crédit Impôt Innovation. Des développeurs performants, sérieux et très professionnels, je recherche un moyen pour les cloner. De Antoine Roussel (Directeur de production chez Textuel La mine). Et voilà c'est la fin de l'aventure @opsone. Merci à tous pour ces 2 supers années! 7, mail Barthélémy Thimonnier. 77185 Lognes - FRANCE. 33 (0)1 85 42 00 10.
